AFP and hepatocellular carcinoma: The results showed that the combined model of radiomics labels, AFP ≥ 400 ng/mL, and arterial rim enhancement had good performance and model calibration, which may provide a preoperative evaluation tool to predict CK19 status and guide individualized management in HCC patients.